Former head of Turing Pharmaceuticals, known for hiking price of Daraprim, could see charges related to another drug company he ran, attorneys sayMartin Shkreli, the reviled former drug company entrepreneur, may face yet more charges in a securities fraud investigation, his defense attorneys revealed at a hearing on Tuesday in New York City.